The Phase II study of the ZyCoV-D vaccine was conducted in more than 1,000 healthy adult volunteers as part of an adaptive Phase I/II dose escalation, multicenter, randomized, double-blind placebo controlled study. The vaccine was found to be safe and immunosuppressive. Watch the video to find out more.
.